Quarterly report · Q2
7681.TEDINET S100TEYE
Period2023-10-01 → 2024-03-31
Filed2024-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.2bn | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥26.6bn | 2022-10-01 → 2023-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.7bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | ¥358m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥263m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥358m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥432m | 2022-10-01 → 2023-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥249m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥358m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥249m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥221m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥271m | 2022-10-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥144m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥229m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥154m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥13.5bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥14.7bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥15.3bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.7bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥9.0bn | at 2023-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥5.9bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥5.7bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥5.6bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.9bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.5bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.9bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.5bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.5bn | at 2022-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥521m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥342m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥219m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥23m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥82m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥55m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥100m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥202m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥118m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥112.46 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥71.45 | 2024-01-01 → 2024-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥138.37 | 2022-10-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥73.31 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.68 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥111.78 | 2023-10-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥137.52 | 2022-10-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥73.09 | 2022-10-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 42.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.9% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.4% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | ¥1m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥211m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥211m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥7m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥372m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥372m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥31m |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥11.6bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥11.6bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥319m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2024-03-31 | ¥12.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2024-03-31 | ¥12.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2024-03-31 | ¥357m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | ¥1m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥205m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥205m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥4m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥362m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥362m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥39m |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥11.1bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥11.1bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥219m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-10-01 → 2023-03-31 | ¥11.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-10-01 → 2023-03-31 | ¥11.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-10-01 → 2023-03-31 | ¥262m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 500
| Item | Context | Value | Unit |
|---|---|---|---|
| Net cash provided by used in investment activities | Prior1YTDDuration | -54520000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -22856000 | JPY |
| Redemption of bonds fin cf | Prior1YTDDuration | -8750000 | JPY |
| Redemption of bonds fin cf | CurrentYTDDuration | － | JPY |
| Repayments of lease obligations fin cf | Prior1YTDDuration | -955000 | JPY |
| Repayments of lease obligations fin cf | CurrentYTDDuration | -432000 | JPY |
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | Prior1YTDDuration | － | JPY |
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | CurrentYTDDuration | 3200000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -97946000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -97900000 | JPY |
| Dividends paid to non controlling interests fin cf | Prior1YTDDuration | -10200000 | JPY |
| Dividends paid to non controlling interests fin cf | CurrentYTDDuration | -4500000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -117851000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -99632000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | -391313000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 398326000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 5460189000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 5517421000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 5068876000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 5915747000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration | 476923000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 496772000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 89216000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 95246000 | JPY |
| Provision for directors bonuses sga | Prior1YTDDuration | 8400000 | JPY |
| Provision for directors bonuses sga | CurrentYTDDuration | 8400000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 25463000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 18597000 | JPY |
| Provision for directors retirement benefits sga | Prior1YTDDuration | 16492000 | JPY |
| Provision for directors retirement benefits sga | CurrentYTDDuration | 27875000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | 54000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | -34000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E34455-000TotalMedicalSolutionBusinessReportableSegmentMember | 11095195000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E34455-000RemoteImageDiagnosisServiceBusinessReportableSegmentMember | 361886000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E34455-000FoodServiceReportableSegmentMember | 205087000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 11662168000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 11662168000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E34455-000TotalMedicalSolutionBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E34455-000RemoteImageDiagnosisServiceBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E34455-000FoodServiceReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E34455-000TotalMedicalSolutionBusinessReportableSegmentMember | 11095195000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E34455-000RemoteImageDiagnosisServiceBusinessReportableSegmentMember | 361886000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E34455-000FoodServiceReportableSegmentMember | 205087000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 11662168000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration | 11662168000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |